6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
43m ago	Nexteer Introduces Market-Ready EMB at Auto China 2026, Advancing Comprehensive Motion Control Solutions
44m ago	Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
44m ago	Calbee Brings Body Granola to Singapore
44m ago	Tavira selects Broadridge to Support its Agency Brokerage Platform and Market Connectivity
1h ago	BetterInvesting™ Magazine Update on The Charles Schwab Corp. (NYSE: SCHW) and Dollar General Corp. (NYSE: DG)

About

Addex Therapeutics Ltd (SW:ADXN) — investor relations, events, news, and company updates on 6ix.

Latest News

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model

Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment

Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia

Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

Financials

Revenue

CHF158.54 K

Market Cap

CHF6.33 M

EPS

-0.06

Community Chat

Ask AI